In recent years, key mental health indicators across the country have been declining, particularly among youth. Policymakers continue to be concerned with the ability of the healthcare system to meet the demand of increasing substance use and mental health challenges. In August, Impact Health shared a policy update to provide an overview of the legislative updates, comment opportunities, recent data, and programmatic… (Marceno, December 5, 2023) #Mental and Behavioral Health, #Opioids, #Prevention

Today, the Centers for Medicare and Medicaid Services (CMS) released an interim final rule with a comment period regarding the unwinding of continuous coverage requirements. The interim final rule outlines CMS’ enforcement of states’ compliance with reporting requirements and renewal requirements during the period that begins on July 1, 2023 and ends on June 30, 2024. In the rule, CMS… (Marceno, December 4, 2023) #Coverage Decisions, #COVID-19, #Insurance Coverage

The House Energy and Commerce (E&C) Oversight and Investigations Subcommittee convened a hearing to examine the Centers for Disease Control and Prevention (CDC) preparedness for the upcoming respiratory disease season, and the agency’s recent restructuring efforts, designed to bolster operational, communication, workforce, and response capabilities. The Subcommittee heard from the new CDC Director Mandy Cohen (testimony), who highlighted the CDC’s… (Colocho, December 4, 2023) #COVID-19, #Prevention, #Public Health, #Transparency

The Department of Health and Human Services (HHS) Office of the Inspector General (OIG) released a report showing that some states made Medicaid capitation payments to managed care organizations (MCOs) on behalf of deceased enrollees. OIG says that 14 previous audits found that state Medicaid agencies had improperly made payments on behalf of deceased enrollees and that the Senate Finance Committee… (McClurg, December 1, 2023) #Program Integrity

The Department of Agriculture (USDA) Food and Nutrition Service (FNS) announced two research-based funding opportunities to develop a subgrant program related to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and maternal health. The two opportunities are described below: Funding Opportunity: FY24 Participation in WIC & Prevalence of Health Risks Associated With Maternal Mortality Description: This grant… (McClurg, December 1, 2023) #Nutrition

The House Budget Committee held a hearing with members from both parties and chambers of Congress to discuss legislative proposals that would establish a bipartisan, bicameral fiscal commission with the goal of reducing the federal debt and improving fiscal sustainability. Members from both parties repeatedly emphasized the worsening deficit and interest levels and many highlighted Medicare and Social Security insolvency as one… (McClurg, November 29, 2023) #Budget

The Biden-Harris Administration announced crucial measures aimed at strengthening the nation’s medical supply chain resilience. The Department of Health and Human Services (HHS) detailed that President Biden plans to issue a Presidential Determination under Title III of the Defense Production Act to expand HHS authorities, allowing investment in domestic manufacturing of essential medicines and medical countermeasures. HHS emphasized the importance… (Colocho, November 29, 2023) #Generic Drugs, #Medical Devices, #Prevention, #Public Health

The Departments of Health and Human Services, Labor, and Treasury released Frequently Asked Questions (FAQs) explaining how the batching requirements of the No Surprises Act (NSA) apply to the Federal Independent Dispute Resolution (IDR) process, in light of the U.S. District Court for the Eastern District of Texas decision in TMA IV and TMA III. The District Court invalidated the… (Llamas, November 28, 2023) #Hospitals, #Physicians

The Food and Drug Administration (FDA) issued a final rule to amend its regulations regarding direct-to-consumer (DTC) advertisements for prescription drugs presented in television or radio format to ensure that the major statement relating to side effects and contraindications are be presented in a clear, conspicuous, and neutral manner. What is it. The final rule implements a requirement of the… (Slifer, November 27, 2023) #Food and Drug Administration, #Prescription Drugs

The Centers for Medicare and Medicaid Services (CMS) released the Medicare Part D Manufacturer Program final guidance, pursuant to the Inflation Reduction Act, that becomes effective beginning January 1, 2025. CMS also released the Manufacturer Discount Program Manufacturer Agreement, and the Manufacturer Discount Program Third Party Administrator (TPA) Agreement. Additional details from the final guidance follow: What is it. The… (Slifer, November 17, 2023) #Medicare Part D, #Prescription Drugs